231 related articles for article (PubMed ID: 10604117)
1. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
2. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
Rindi G; Bordi C
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
[TBL] [Abstract][Full Text] [Related]
3. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
[TBL] [Abstract][Full Text] [Related]
4. Tumour biology and histopathology of neuroendocrine tumours.
Klöppel G
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
7. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
9. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Arnold R
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
11. The gastroenteropancreatic endocrine system and related tumors.
Solcia E; Capella C; Fiocca R; Cornaggia M; Bosi F
Gastroenterol Clin North Am; 1989 Dec; 18(4):671-93. PubMed ID: 2575601
[TBL] [Abstract][Full Text] [Related]
12. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
[TBL] [Abstract][Full Text] [Related]
13. Highlights of the biology of endocrine tumours of the gut and pancreas.
Rindi G; Bordi C
Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
[TBL] [Abstract][Full Text] [Related]
14. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
[TBL] [Abstract][Full Text] [Related]
15. [Coexistence of two different neuroendocrine tumors of the upper gastrointestinal tract and of the pancreas].
Ritter MR; Höppner W
Dtsch Med Wochenschr; 1999 Jun; 124(22):712; discussion 713. PubMed ID: 10394354
[No Abstract] [Full Text] [Related]
16. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of sporadic pancreatic endocrine tumours.
Perren A; Roth J; Muletta-Feurer S; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
J Pathol; 1998 Dec; 186(4):363-71. PubMed ID: 10209484
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
[TBL] [Abstract][Full Text] [Related]
20. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]